These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32022845)

  • 1. Promise of autologous CD34+ stem/progenitor cell therapy for treatment of cardiovascular disease.
    Prasad M; Corban MT; Henry TD; Dietz AB; Lerman LO; Lerman A
    Cardiovasc Res; 2020 Jul; 116(8):1424-1433. PubMed ID: 32022845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
    Povsic TJ; Henry TD; Traverse JH; Fortuin FD; Schaer GL; Kereiakes DJ; Schatz RA; Zeiher AM; White CJ; Stewart DJ; Jolicoeur EM; Bass T; Henderson DA; Dignacco P; Gu Z; Al-Khalidi HR; Junge C; Nada A; Hunt AS; Losordo DW;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1576-85. PubMed ID: 27491607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary autologous CD34+ stem cell therapy for intractable angina.
    Wang S; Cui J; Peng W; Lu M
    Cardiology; 2010; 117(2):140-7. PubMed ID: 20975266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.
    Mackie AR; Losordo DW
    Tex Heart Inst J; 2011; 38(5):474-85. PubMed ID: 22163120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of CD34+ cells for myocardial ischemia.
    Matta A; Nader V; Galinier M; Roncalli J
    World J Transplant; 2021 May; 11(5):138-146. PubMed ID: 34046316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Arteries.
    Corban MT; Toya T; Albers D; Sebaali F; Lewis BR; Bois J; Gulati R; Prasad A; Best PJM; Bell MR; Rihal CS; Prasad M; Ahmad A; Lerman LO; Solseth ML; Winters JL; Dietz AB; Lerman A
    Circ Res; 2022 Feb; 130(3):326-338. PubMed ID: 34923853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous Cell Therapy for Vascular Regeneration: The Role of Proangiogenic Cells.
    Bianconi V; Fallarino F; Mannarino MR; Bagaglia F; Kararoudi MN; Aragona CO; Romani R; Pirro M
    Curr Med Chem; 2018; 25(35):4518-4534. PubMed ID: 29022506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous CD34+ Cell Therapy for Ischemic Tissue Repair.
    Sietsema WK; Kawamoto A; Takagi H; Losordo DW
    Circ J; 2019 Jun; 83(7):1422-1430. PubMed ID: 31178469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct.
    Pasquet S; Sovalat H; Hénon P; Bischoff N; Arkam Y; Ojeda-Uribe M; Bouar Rl; Rimelen V; Brink I; Dallemand R; Monassier JP
    Cytotherapy; 2009; 11(8):1002-15. PubMed ID: 19929464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ex vivo produced endothelial progenitor cells for autologous transplantation in primates.
    Qin M; Guan X; Zhang Y; Shen B; Liu F; Zhang Q; Ma Y; Jiang Y
    Stem Cell Res Ther; 2018 Jan; 9(1):14. PubMed ID: 29357928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
    Kawamoto A; Asahara T
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function.
    Leone AM; Rutella S; Bonanno G; Abbate A; Rebuzzi AG; Giovannini S; Lombardi M; Galiuto L; Liuzzo G; Andreotti F; Lanza GA; Contemi AM; Leone G; Crea F
    Eur Heart J; 2005 Jun; 26(12):1196-204. PubMed ID: 15734770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials.
    Velagapudi P; Turagam M; Kolte D; Khera S; Hyder O; Gordon P; Aronow HD; Leopold J; Abbott JD
    Cardiovasc Revasc Med; 2019 Mar; 20(3):215-219. PubMed ID: 29908826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes.
    Wojakowski W; Tendera M
    Folia Histochem Cytobiol; 2005; 43(4):229-32. PubMed ID: 16382890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular Regeneration With New Sources of Endothelial Cells.
    Lee S; Lee SJ; Yoon YS
    Circ Res; 2019 Jan; 124(1):29-31. PubMed ID: 30605418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous CD34
    Henry TD; Schaer GL; Traverse JH; Povsic TJ; Davidson C; Lee JS; Costa MA; Bass T; Mendelsohn F; Fortuin FD; Pepine CJ; Patel AN; Riedel N; Junge C; Hunt A; Kereiakes DJ; White C; Harrington RA; Schatz RA; Losordo DW;
    Cell Transplant; 2016; 25(9):1701-1711. PubMed ID: 27151378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Stem/Progenitor Cells as Prognostic Biomarkers in Macro- and Microvascular Disease: A Narrative Review of Prospective Observational Studies.
    Rigato M; Fadini GP
    Curr Med Chem; 2018; 25(35):4507-4517. PubMed ID: 28933297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction.
    Massa M; Rosti V; Ferrario M; Campanelli R; Ramajoli I; Rosso R; De Ferrari GM; Ferlini M; Goffredo L; Bertoletti A; Klersy C; Pecci A; Moratti R; Tavazzi L
    Blood; 2005 Jan; 105(1):199-206. PubMed ID: 15345590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34+ autologous human stem cells in treating refractory angina.
    Perin EC; Willerson JT
    Circ Res; 2011 Aug; 109(4):351-2. PubMed ID: 21817161
    [No Abstract]   [Full Text] [Related]  

  • 20. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction.
    Shim Y; Nam MH; Hyuk SW; Yoon SY; Song JM
    Anal Chim Acta; 2015 Jan; 853():501-507. PubMed ID: 25467496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.